Real-Time Fortitude Of Emtricitabine, Dolutegravir And Tenofovir In Pharmaceutical Dosage By Rp-Hplc Method Through Stability Studies

Authors

  • Pavan Kumar Kasu , Battu Satyanarayana

DOI:

https://doi.org/10.47750/pnr.2022.13.S09.76

Abstract

An accurate, an efficient, sensitive, stability indicting RP-HPLC method has designed and developed and authenticated for the instantaneous determination of Emtricitabine, Dolutegravir and Tenofovir by pharmaceutical dosage method. The retention time of the Emtricitabine (ECT) Dolutegravir (DTG) and Tenofovir (TEN) 2.088, 2.491 and 2.919 minutes respectively compared with standard drugs retention time.

Downloads

Published

2022-11-12 — Updated on 2022-11-12

Versions

How to Cite

Pavan Kumar Kasu , Battu Satyanarayana. (2022). Real-Time Fortitude Of Emtricitabine, Dolutegravir And Tenofovir In Pharmaceutical Dosage By Rp-Hplc Method Through Stability Studies. Journal of Pharmaceutical Negative Results, 678–689. https://doi.org/10.47750/pnr.2022.13.S09.76

Issue

Section

Articles